Product Profiles

Article

A round-up of the latest ophthalmic products

Reuseable accessories

Available from Geuder is a series of accessories for the Uno Colorline Trocar system, enabling seamless vitrectomy procedures.

Non-mydriatic colour fundus camera

Optovue has developed the iCam, a nonmydriatic compact fundus camera.

iCam enables practitioners to obtain high-quality, easy to use fundus photography of various pathologies. It features joystick control and a user interface that provides image review and EMR communication.

Further details can be found at http://www.optovue.com/

Blepharitis treatment range

The Blepharitis Relief Kit, available from Altacor, is designed to assist in clearing the meibomian glands and optimizing lid hygiene.

Please go to http://www.altacoreyeproducts.com/ for more details.

Local ophthalmic computer network

The Oculus Floating License Key is a local computer network that supports the software of all Oculus devices and allows easy access to patient examination results.

Examination results can be accessed at every workstation connected to the local network, meaning patient consultation is improved and clinic efficiency is increased.

For more details please go to http://www.oculus.de/

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.